U.S. and World News
:
Business
:
Reports and Studies
News
New Report Examines Pharmaceutical Sales Force Effectiveness
Mon, 07 Jul 2008, 10:20:12 EDT
Eularis Challenges Pharma Industry: Are You Measuring the Wrong Things?
LONDON UK, and TOKYO Japan, July 7 (SEND2PRESS NEWSWIRE) -- With the ever-increasing pressure to ensure maximum return on investment, sales force effectiveness is becoming a high priority in the global pharmaceutical industry. Reports have shown that while sales forces represent the largest spend in pharma sales and marketing, return on this investment has declined sharply in recent years. To address this alarming issue, Eularis announces today the availability of its new report, "Pharmaceutical Sales Force Effectiveness Metrics: Are You Measuring the Wrong Things?"
 Written for CEOs, marketing executives and sales executives, this comprehensive research project examines market data and case studies and reports the startling discovery that the very metrics currently being used to assess sales force effectiveness are in fact the ones causing its decline. Focusing on the pharmaceutical industries in the United States, Europe and Japan, the report dissects these current metrics and their limitations, and then offers updated metrics that can help solve the declining effectiveness crisis.
"A pharmaceutical organization's spending on sales force is second only to research and development. Better metrics must be used to measure both the effectiveness and financial impact of this very significant budget element because the current measurements used by most top pharma today actually contribute to the decline in effectiveness of the field force," commented the author of the report, Dr. Andree K. Bates, president of Eularis.
Traditional pharmaceutical organizations are rigorously tracking and managing sales activity, but still falling short. Data emerging from the research concludes that current metrics are more focused on efficiencies rather than effectiveness - and do so to their own detriment.
The report also identifies core issues at play in SFE, such as:
* Why sales call frequency metrics are deeply flawed
* What impact the marketing message has on the customer during the detail
* Which SFE issues vary by region
* How to target the right audiences
* How to incorporate appropriate influencing behaviors into SFE programs
The report discusses appropriate tactics to solve these problems, and demonstrates implementation methods and issues. Sales force effectiveness is a difficult concept to measure, but doing so can push pharmaceutical companies past today's hurdles and into increased productivity and sales.
"Implementing new sales force effectiveness metrics that actually improve effectiveness, and navigating the tricky paths of assessment, changing behaviors, and incorporating eDetailing and CRM systems can be challenging, but it doesn't have to be if you're measuring the right things. Cutting-edge pharmaceutical marketers are turning to appropriate analytics to play an important role in ensuring change is on the right path," closed Bates.
Bates has gained wide recognition within the international pharmaceutical industry for her expertise in marketing return analysis. In addition to this and other must-have reports for pharmaceutical industry marketers, she has authored many articles in peer-reviewed journals and several chapters in books on pharmaceutical analytics.
To purchase the Eularis report, "Pharmaceutical Sales Force Effectiveness Metrics: Are You Measuring the Wrong Things?" visit: http://www.pharmaindustrysfe.com/ or http://www.eularis.com/japanese/marketing-excellence/market-reports.asp
About Eularis
Eularis provides sophisticated pharmaceutical analytics that provide data-driven insight into the financial impact of corporate and marketing decisions. Unlike traditional analytics approaches which are lengthy and whose reliance on historical or analogue data reduces their accuracy, Eularis' proprietary 94.8 Analytics Process is based on the current market situation. This proven approach helps pharmaceutical marketing teams to quickly plan, measure, validate, and optimize their sales and marketing performance. Eularis offers pre-launch analytics, marketing mix modeling (both professional and consumer), portfolio optimization, sales force effectiveness, managed care analytics, and patient compliance solutions. Co-headquartered in London and New York City, the company has developed significant experience in the global pharmaceutical market through client engagements globally (including Japan and Asia Pacific) with AstraZeneca, GlaxoSmithKline, Merck, Pfizer and many others. For more information about Eularis, visit www.eularis.com.
All trademarks acknowledged.
NEWS SOURCE: Eularis
Send2Press® is the originating wire service for this story.
» Read More Reports and Studies News
» Other Send2Press Industry News by Category
More Information and Media Contact:
For questions about this story, contact the news source:
»
Click Here for Contact Information
THE CONTENT OF THE ABOVE NEWS STORY WAS PROVIDED BY THE NEWS SOURCE WHO IS SOLELY RESPONSIBLE FOR ITS ACCURACY. FOR QUESTIONS ABOUT THIS STORY CONTACT THE NEWS SOURCE AND NOT SEND2PRESS (THIS WEBSITE).
O T H E R R E S O U R C E S
T E R M S O F U S E
This article is Copr. © 1983-2008 Neotrope / Send2Press. Reproduction of this news article version requires written authorization. You may freely link to this article. Journalists (see the section "Journalist Resources" above) may use orig. news release as the basis for an article.
News Websites may republish the "news release" text version linked to above under "Journalist Resources" except must retain "Send2Press Newswire" as the source of this news if used verbatim. Websites which offer/sell PR or newswire services, or web promotion services, or "splogs" may NOT reprint our content in ANY form. Send2Press Newswire is a service mark of, and "Send2Press" is a registered trademark of, Neotrope. Creative Commons - Some Rights Reserved (3.0) - Attribution Required.
DISCLAIMER: the above article is believed accurate but not guaranteed, and is based on business news supplied by the source (Eularis). The noted source is solely responsible for its accuracy. Financial/Stock news may contain forward looking statements. Neotrope/Send2Press makes no claims of accuracy or suitability for any purpose. Any opinions expressed by representatives of company(s) mentioned in news and profiles are solely those of the person indicated, and do not reflect any opinion or policy of Neotrope or Send2Press. Your use of any information contained herein is done solely at your own risk, and you are fully responsible for using any information herein, or on sites mentioned or linked to in the article. All trademarks acknowledged.
REFERENCES: New Report Examines Pharmaceutical Sales Force Effectiveness, Eularis, Pharmaceutical Sales Force Effectiveness Metrics: Are You Measuring the Wrong Things, Jul 7, 2008.
VIEWED BY MEDIA (and public): 1056 times (1 today, 12 this week,
44 this month, 1056 this year)
| Targeting Metastatic Cancer from the Inside: Epeius Biotech Reveals a New Generation of Tools for Medical Gene Delivery |
| New Survey Provides Insights from Users of Over 80 Restaurant Point of Sale Systems |
| Telephone Companies Ready to Offer Green Services Promoting Environmental Improvements, says INSIGHT Research |
| Eularis Releases First-Ever Study on ROI of Pre-Launch Named Patient Programmes |
| Spending on Telecommunications Private Line Services to Hit $40.6 Billion in 2008, Says Insight Research Corporation |
| Worldwide Mobile Content Tools Market to Top $8 Billion in 2008, says INSIGHT Research Corp. |
| Telecommunications Gateway Market Now Showing Solid Growth, Says Insight Research |
| Invest in People Power to Fight Recession |
| New Devices Move Internet Videos Off PCs and Into Homes, Changing TV Forever, says Insight Research |
| Eularis Analyzes Most Effective Generics Defense Strategies with New Pharmaceutical Industry Report |
| New Report Examines Pharmaceutical Sales Force Effectiveness |
| The Telecommunications Industry Stands to Make $1 Trillion over Five Years Promoting Environmental Improvements, says Insight Research |
| Optical Networking Equipment Sales to Top $120 Billion Over Five Years, Says Insight Research Corp. |
| Healthcare Industry Spending on Telecommunications Services Hits $55 Billion Over Next Five Years, says Insight Research |
| Business Leaders Expect No Growth from the Private Equity Market Over the Next 12 Months, Shows New Research |
| Hispanics and Other Ethnic Markets Will Spend $60 Billion on Telecommunications, says Insight Research |
| IPTV, Streaming Movie and Music Industry Will Generate $70 Billion Over Six Years, says Insight Research |
| Eularis Exposes Hidden Barriers to Patient Adherence with New Pharmaceutical Industry Report |
| Petrobras World's Most Sustainable Oil/Gas Company 2008 |
| Corporate Phone Bill Will Hit $133 Billion in 2008, Says Insight Research |
| New Copper Bonding Products for Telecommunications Will Grow Carrier Ethernet and Wireless Backhaul Markets Worldwide, Says Insight Research Corporation |
| Ballantine Corporation Releases Direct Mail Format Report |
| Telecom IT Spending to Exceed $46 Billion in 2008, says Insight Research Corp. |
| New Report Examines Pharmaceutical Sales Force Effectiveness |
| Spending on Managed Services Increasing As Enterprises Turn to Outsourcing to Handle Complexity, Says Insight Research |
» View All News Channels
» Press Release Services
» Send2Press Home Page
|
|
|
|
|
Subscribe in a reader
PLAIN TEXT FORMAT (UTF-8)
PDF FORMAT
